Tenet Healthcare vs United Therapeutics

Tenet Healthcare (THC), health care, and United Therapeutics (UTHR), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

United Therapeutics is worth $24.9B on the stock market and Tenet Healthcare $22.4B: United Therapeutics is valued at 11% more. Tenet Healthcare trades at 8.2 times earnings and United Therapeutics at 22.0; operating margins in their latest fiscal years were 16.5% and 46.9%. Over the past year Tenet Healthcare's share price has moved +51.1% and United Therapeutics's +23.4%.

Key facts

Tenet Healthcare market value
$22.4B
United Therapeutics market value
$24.9B
Tenet Healthcare P/E
8.2
United Therapeutics P/E
22.0
Tenet Healthcare revenue
$21.3BFY to 2025-12-31
United Therapeutics revenue
$3.2BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Tenet Healthcare vs United Therapeutics: every measure side by side
Measure Tenet Healthcare United Therapeutics
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$22.4Blower$24.9Bhigher
Revenue$21.3Bhigher$3.2Blower
Earnings$2.4Bhigher$1.3Blower
Employees77,000higher1,400lower
Total assets$29.7Bhigher$7.9Blower
Valuation
P/E8.2lower22.0higher
P/S1.1lower7.8higher
P/B4.1higher3.9lower
Dividend yield0.00%0.00%
Profitability
Operating margin16.5%lower46.9%higher
Balance sheet
Net assets$4.2Blower$7.1Bhigher
Total liabilities$20.7Bhigher$783.8Mlower
Total debt$13.3B—
Cash on hand$2.9Bhigher$1.6Blower
Price change
Today-3.25%lower-0.64%higher
1 year+51.1%higher+23.4%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Tenet Healthcare only (3)

Percentages are each holding's share of that investor's reported portfolio. Who owns THC · Who owns UTHR

Further comparisons

Learn

Questions and answers

Which is bigger, Tenet Healthcare or United Therapeutics?

By market value, United Therapeutics is the larger: $24.9B against $22.4B for Tenet Healthcare. By revenue in its latest fiscal year, Tenet Healthcare is the larger: $21.3B against $3.2B for United Therapeutics.

Which has the higher P/E ratio?

United Therapeutics: 22.0, against 8.2 for Tenet Healthcare. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

United Therapeutics: 46.9%, against 16.5% for Tenet Healthcare. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Tenet Healthcare and United Therapeutics?

None of the tracked superinvestors holds both in their latest 13F filing. 3 hold Tenet Healthcare and 4 hold United Therapeutics.

Cite this page

Funkfolio, “Tenet Healthcare vs United Therapeutics”, data as of 18 November 2026. https://funkfolio.com/compare/thc-vs-uthr

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.